Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells

One of the pathological hallmarks of amyotrophic lateral sclerosis (ALS) is mislocalized, cytosolic aggregation of TAR DNA-Binding Protein-43 (TDP-43). Not only TDP-43 per se is a causative gene of ALS but also mislocalization and aggregation of TDP-43 seems to be a common pathological change in bot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Laboratory investigation 2021-10, Vol.101 (10), p.1331-1340
Hauptverfasser: Yamanaka, Yoshiaki, Miyagi, Tamami, Harada, Yuichiro, Kuroda, Masahiko, Kanekura, Kohsuke
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1340
container_issue 10
container_start_page 1331
container_title Laboratory investigation
container_volume 101
creator Yamanaka, Yoshiaki
Miyagi, Tamami
Harada, Yuichiro
Kuroda, Masahiko
Kanekura, Kohsuke
description One of the pathological hallmarks of amyotrophic lateral sclerosis (ALS) is mislocalized, cytosolic aggregation of TAR DNA-Binding Protein-43 (TDP-43). Not only TDP-43 per se is a causative gene of ALS but also mislocalization and aggregation of TDP-43 seems to be a common pathological change in both sporadic and familial ALS. The mechanism how nuclear TDP-43 transforms into cytosolic aggregates remains elusive, but recent studies using optogenetics have proposed that aberrant liquid–liquid phase separation (LLPS) of TDP-43 links to the aggregation process, leading to cytosolic distribution. Although LLPS plays an important role in the aggregate formation, there are still several technical problems in the optogenetic technique to be solved to progress further in vivo study. Here we report a chemically oligomerizable TDP-43 system. Oligomerization of TDP-43 was achieved by a small compound AP20187, and oligomerized TDP-43 underwent aggregate formation, followed by cytosolic mislocalization and induction of cell toxicity. The mislocalized TDP-43 co-aggregated with wt-TDP-43, Fused-in-sarcoma (FUS), TIA1 and sequestosome 1 (SQSTM1)/p62, mimicking ALS pathology. The chemically oligomerizable TDP-43 also revealed the roles of the N-terminal domain, RNA-recognition motif, nuclear export signal and low complexity domain in the aggregate formation and mislocalization of TDP-43. The aggregate-prone properties of TDP-43 were enhanced by a familial ALS-causative mutation. In conclusion, the chemically oligomerizable TDP-43 system could be useful to study the mechanisms underlying the droplet-aggregation phase transition and cytosolic mislocalization of TDP-43 in ALS and further study in vivo. TDP-43 is the primary protein aggregate in amyotrophic lateral sclerosis (ALS), and its mislocalization from nucleus is a hallmark of ALS pathology whose mechanisms remain unclear. In this study, the authors report a novel chemically oligomerizable TDP-43 system. Induction of TDP-43 oligomerization mimics ALS pathology such as mislocalization of TDP-43 and recruitment of critical proteins into the aggregates.
doi_str_mv 10.1038/s41374-021-00623-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2572354611</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0023683722003968</els_id><sourcerecordid>2572354611</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-109b3b640fcd1b44599eda74e227c595c7540be802e6816d779c40028a2ec1473</originalsourceid><addsrcrecordid>eNp9kUuLFDEUhYMoTjv6B1xIwHU0z0oVuGnG8QGDgozrkErd7sqQR5tUj7T_wf9stEbdzSpwc75zk3MQes7oK0ZF_7pKJrQklDNCaccFkQ_QhilBCRVUP0QbStuw64U-Q09qvaGUSdmpx-hMNJJxrTfo52Vd7Bh8nSOkBecddjNE72wIJ5yD3-cIxf9oEsDX2y_47actGX2afNrjQ8kL-ESkwN9n72YcfSMrtvGUl5IPbYaDXaDYgKsLUHL1FR_sMueQ9yfsE442Rhu8TdhBCPUperSzocKzu_McfX13eX3xgVx9fv_xYntFnBL9QhgdRjF2ku7cxEYp1TDAZLUEzrVTg3JaSTpCTzl0PesmrQcnWxi95eCY1OIcvVx92xe-HaEu5iYfS2orDVeaCyU7xpqKryrXXl4L7Myh-GjLyTBqfjdg1gZMa8D8acDIBr24sz6OEaZ_yN_Im0Csgtqu0h7K_9332r5ZKWix3PpGVechOZh8AbeYKfv78F-xEKXk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2572354611</pqid></control><display><type>article</type><title>Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Yamanaka, Yoshiaki ; Miyagi, Tamami ; Harada, Yuichiro ; Kuroda, Masahiko ; Kanekura, Kohsuke</creator><creatorcontrib>Yamanaka, Yoshiaki ; Miyagi, Tamami ; Harada, Yuichiro ; Kuroda, Masahiko ; Kanekura, Kohsuke</creatorcontrib><description>One of the pathological hallmarks of amyotrophic lateral sclerosis (ALS) is mislocalized, cytosolic aggregation of TAR DNA-Binding Protein-43 (TDP-43). Not only TDP-43 per se is a causative gene of ALS but also mislocalization and aggregation of TDP-43 seems to be a common pathological change in both sporadic and familial ALS. The mechanism how nuclear TDP-43 transforms into cytosolic aggregates remains elusive, but recent studies using optogenetics have proposed that aberrant liquid–liquid phase separation (LLPS) of TDP-43 links to the aggregation process, leading to cytosolic distribution. Although LLPS plays an important role in the aggregate formation, there are still several technical problems in the optogenetic technique to be solved to progress further in vivo study. Here we report a chemically oligomerizable TDP-43 system. Oligomerization of TDP-43 was achieved by a small compound AP20187, and oligomerized TDP-43 underwent aggregate formation, followed by cytosolic mislocalization and induction of cell toxicity. The mislocalized TDP-43 co-aggregated with wt-TDP-43, Fused-in-sarcoma (FUS), TIA1 and sequestosome 1 (SQSTM1)/p62, mimicking ALS pathology. The chemically oligomerizable TDP-43 also revealed the roles of the N-terminal domain, RNA-recognition motif, nuclear export signal and low complexity domain in the aggregate formation and mislocalization of TDP-43. The aggregate-prone properties of TDP-43 were enhanced by a familial ALS-causative mutation. In conclusion, the chemically oligomerizable TDP-43 system could be useful to study the mechanisms underlying the droplet-aggregation phase transition and cytosolic mislocalization of TDP-43 in ALS and further study in vivo. TDP-43 is the primary protein aggregate in amyotrophic lateral sclerosis (ALS), and its mislocalization from nucleus is a hallmark of ALS pathology whose mechanisms remain unclear. In this study, the authors report a novel chemically oligomerizable TDP-43 system. Induction of TDP-43 oligomerization mimics ALS pathology such as mislocalization of TDP-43 and recruitment of critical proteins into the aggregates.</description><identifier>ISSN: 0023-6837</identifier><identifier>EISSN: 1530-0307</identifier><identifier>DOI: 10.1038/s41374-021-00623-4</identifier><identifier>PMID: 34131277</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>13 ; 13/51 ; 14 ; 14/19 ; 14/35 ; 631/1647/767/1658 ; 64 ; 692/617/375/1917/1285 ; 82 ; 96 ; Agglomeration ; Aggregates ; Amyotrophic lateral sclerosis ; Amyotrophic Lateral Sclerosis - metabolism ; Amyotrophic Lateral Sclerosis - pathology ; Biocompatibility ; Deoxyribonucleic acid ; DNA ; DNA-binding protein ; DNA-Binding Proteins - chemistry ; DNA-Binding Proteins - genetics ; DNA-Binding Proteins - metabolism ; FUS protein ; Genetics ; HEK293 Cells ; HeLa Cells ; Humans ; In vivo methods and tests ; Information processing ; Laboratory Medicine ; Liquid phases ; Mammalian cells ; Medicine ; Medicine &amp; Public Health ; Mimicry ; Mutation ; Nuclear transport ; Oligomerization ; Optics ; Pathology ; Phase separation ; Phase transitions ; Proteins ; RNA transport ; Sarcoma ; Toxicity</subject><ispartof>Laboratory investigation, 2021-10, Vol.101 (10), p.1331-1340</ispartof><rights>2021 United States &amp; Canadian Academy of Pathology</rights><rights>The Author(s), under exclusive licence to United States and Canadian Academy of Pathology 2021</rights><rights>2021. The Author(s), under exclusive licence to United States and Canadian Academy of Pathology.</rights><rights>The Author(s), under exclusive licence to United States and Canadian Academy of Pathology 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-109b3b640fcd1b44599eda74e227c595c7540be802e6816d779c40028a2ec1473</citedby><cites>FETCH-LOGICAL-c538t-109b3b640fcd1b44599eda74e227c595c7540be802e6816d779c40028a2ec1473</cites><orcidid>0000-0001-7052-4289 ; 0000-0002-2901-9595</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34131277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamanaka, Yoshiaki</creatorcontrib><creatorcontrib>Miyagi, Tamami</creatorcontrib><creatorcontrib>Harada, Yuichiro</creatorcontrib><creatorcontrib>Kuroda, Masahiko</creatorcontrib><creatorcontrib>Kanekura, Kohsuke</creatorcontrib><title>Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells</title><title>Laboratory investigation</title><addtitle>Lab Invest</addtitle><addtitle>Lab Invest</addtitle><description>One of the pathological hallmarks of amyotrophic lateral sclerosis (ALS) is mislocalized, cytosolic aggregation of TAR DNA-Binding Protein-43 (TDP-43). Not only TDP-43 per se is a causative gene of ALS but also mislocalization and aggregation of TDP-43 seems to be a common pathological change in both sporadic and familial ALS. The mechanism how nuclear TDP-43 transforms into cytosolic aggregates remains elusive, but recent studies using optogenetics have proposed that aberrant liquid–liquid phase separation (LLPS) of TDP-43 links to the aggregation process, leading to cytosolic distribution. Although LLPS plays an important role in the aggregate formation, there are still several technical problems in the optogenetic technique to be solved to progress further in vivo study. Here we report a chemically oligomerizable TDP-43 system. Oligomerization of TDP-43 was achieved by a small compound AP20187, and oligomerized TDP-43 underwent aggregate formation, followed by cytosolic mislocalization and induction of cell toxicity. The mislocalized TDP-43 co-aggregated with wt-TDP-43, Fused-in-sarcoma (FUS), TIA1 and sequestosome 1 (SQSTM1)/p62, mimicking ALS pathology. The chemically oligomerizable TDP-43 also revealed the roles of the N-terminal domain, RNA-recognition motif, nuclear export signal and low complexity domain in the aggregate formation and mislocalization of TDP-43. The aggregate-prone properties of TDP-43 were enhanced by a familial ALS-causative mutation. In conclusion, the chemically oligomerizable TDP-43 system could be useful to study the mechanisms underlying the droplet-aggregation phase transition and cytosolic mislocalization of TDP-43 in ALS and further study in vivo. TDP-43 is the primary protein aggregate in amyotrophic lateral sclerosis (ALS), and its mislocalization from nucleus is a hallmark of ALS pathology whose mechanisms remain unclear. In this study, the authors report a novel chemically oligomerizable TDP-43 system. Induction of TDP-43 oligomerization mimics ALS pathology such as mislocalization of TDP-43 and recruitment of critical proteins into the aggregates.</description><subject>13</subject><subject>13/51</subject><subject>14</subject><subject>14/19</subject><subject>14/35</subject><subject>631/1647/767/1658</subject><subject>64</subject><subject>692/617/375/1917/1285</subject><subject>82</subject><subject>96</subject><subject>Agglomeration</subject><subject>Aggregates</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Amyotrophic Lateral Sclerosis - metabolism</subject><subject>Amyotrophic Lateral Sclerosis - pathology</subject><subject>Biocompatibility</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA-binding protein</subject><subject>DNA-Binding Proteins - chemistry</subject><subject>DNA-Binding Proteins - genetics</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>FUS protein</subject><subject>Genetics</subject><subject>HEK293 Cells</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>In vivo methods and tests</subject><subject>Information processing</subject><subject>Laboratory Medicine</subject><subject>Liquid phases</subject><subject>Mammalian cells</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mimicry</subject><subject>Mutation</subject><subject>Nuclear transport</subject><subject>Oligomerization</subject><subject>Optics</subject><subject>Pathology</subject><subject>Phase separation</subject><subject>Phase transitions</subject><subject>Proteins</subject><subject>RNA transport</subject><subject>Sarcoma</subject><subject>Toxicity</subject><issn>0023-6837</issn><issn>1530-0307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUuLFDEUhYMoTjv6B1xIwHU0z0oVuGnG8QGDgozrkErd7sqQR5tUj7T_wf9stEbdzSpwc75zk3MQes7oK0ZF_7pKJrQklDNCaccFkQ_QhilBCRVUP0QbStuw64U-Q09qvaGUSdmpx-hMNJJxrTfo52Vd7Bh8nSOkBecddjNE72wIJ5yD3-cIxf9oEsDX2y_47actGX2afNrjQ8kL-ESkwN9n72YcfSMrtvGUl5IPbYaDXaDYgKsLUHL1FR_sMueQ9yfsE442Rhu8TdhBCPUperSzocKzu_McfX13eX3xgVx9fv_xYntFnBL9QhgdRjF2ku7cxEYp1TDAZLUEzrVTg3JaSTpCTzl0PesmrQcnWxi95eCY1OIcvVx92xe-HaEu5iYfS2orDVeaCyU7xpqKryrXXl4L7Myh-GjLyTBqfjdg1gZMa8D8acDIBr24sz6OEaZ_yN_Im0Csgtqu0h7K_9332r5ZKWix3PpGVechOZh8AbeYKfv78F-xEKXk</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Yamanaka, Yoshiaki</creator><creator>Miyagi, Tamami</creator><creator>Harada, Yuichiro</creator><creator>Kuroda, Masahiko</creator><creator>Kanekura, Kohsuke</creator><general>Elsevier Inc</general><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0001-7052-4289</orcidid><orcidid>https://orcid.org/0000-0002-2901-9595</orcidid></search><sort><creationdate>20211001</creationdate><title>Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells</title><author>Yamanaka, Yoshiaki ; Miyagi, Tamami ; Harada, Yuichiro ; Kuroda, Masahiko ; Kanekura, Kohsuke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-109b3b640fcd1b44599eda74e227c595c7540be802e6816d779c40028a2ec1473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>13</topic><topic>13/51</topic><topic>14</topic><topic>14/19</topic><topic>14/35</topic><topic>631/1647/767/1658</topic><topic>64</topic><topic>692/617/375/1917/1285</topic><topic>82</topic><topic>96</topic><topic>Agglomeration</topic><topic>Aggregates</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Amyotrophic Lateral Sclerosis - metabolism</topic><topic>Amyotrophic Lateral Sclerosis - pathology</topic><topic>Biocompatibility</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA-binding protein</topic><topic>DNA-Binding Proteins - chemistry</topic><topic>DNA-Binding Proteins - genetics</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>FUS protein</topic><topic>Genetics</topic><topic>HEK293 Cells</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>In vivo methods and tests</topic><topic>Information processing</topic><topic>Laboratory Medicine</topic><topic>Liquid phases</topic><topic>Mammalian cells</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mimicry</topic><topic>Mutation</topic><topic>Nuclear transport</topic><topic>Oligomerization</topic><topic>Optics</topic><topic>Pathology</topic><topic>Phase separation</topic><topic>Phase transitions</topic><topic>Proteins</topic><topic>RNA transport</topic><topic>Sarcoma</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamanaka, Yoshiaki</creatorcontrib><creatorcontrib>Miyagi, Tamami</creatorcontrib><creatorcontrib>Harada, Yuichiro</creatorcontrib><creatorcontrib>Kuroda, Masahiko</creatorcontrib><creatorcontrib>Kanekura, Kohsuke</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Laboratory investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamanaka, Yoshiaki</au><au>Miyagi, Tamami</au><au>Harada, Yuichiro</au><au>Kuroda, Masahiko</au><au>Kanekura, Kohsuke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells</atitle><jtitle>Laboratory investigation</jtitle><stitle>Lab Invest</stitle><addtitle>Lab Invest</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>101</volume><issue>10</issue><spage>1331</spage><epage>1340</epage><pages>1331-1340</pages><issn>0023-6837</issn><eissn>1530-0307</eissn><abstract>One of the pathological hallmarks of amyotrophic lateral sclerosis (ALS) is mislocalized, cytosolic aggregation of TAR DNA-Binding Protein-43 (TDP-43). Not only TDP-43 per se is a causative gene of ALS but also mislocalization and aggregation of TDP-43 seems to be a common pathological change in both sporadic and familial ALS. The mechanism how nuclear TDP-43 transforms into cytosolic aggregates remains elusive, but recent studies using optogenetics have proposed that aberrant liquid–liquid phase separation (LLPS) of TDP-43 links to the aggregation process, leading to cytosolic distribution. Although LLPS plays an important role in the aggregate formation, there are still several technical problems in the optogenetic technique to be solved to progress further in vivo study. Here we report a chemically oligomerizable TDP-43 system. Oligomerization of TDP-43 was achieved by a small compound AP20187, and oligomerized TDP-43 underwent aggregate formation, followed by cytosolic mislocalization and induction of cell toxicity. The mislocalized TDP-43 co-aggregated with wt-TDP-43, Fused-in-sarcoma (FUS), TIA1 and sequestosome 1 (SQSTM1)/p62, mimicking ALS pathology. The chemically oligomerizable TDP-43 also revealed the roles of the N-terminal domain, RNA-recognition motif, nuclear export signal and low complexity domain in the aggregate formation and mislocalization of TDP-43. The aggregate-prone properties of TDP-43 were enhanced by a familial ALS-causative mutation. In conclusion, the chemically oligomerizable TDP-43 system could be useful to study the mechanisms underlying the droplet-aggregation phase transition and cytosolic mislocalization of TDP-43 in ALS and further study in vivo. TDP-43 is the primary protein aggregate in amyotrophic lateral sclerosis (ALS), and its mislocalization from nucleus is a hallmark of ALS pathology whose mechanisms remain unclear. In this study, the authors report a novel chemically oligomerizable TDP-43 system. Induction of TDP-43 oligomerization mimics ALS pathology such as mislocalization of TDP-43 and recruitment of critical proteins into the aggregates.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><pmid>34131277</pmid><doi>10.1038/s41374-021-00623-4</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-7052-4289</orcidid><orcidid>https://orcid.org/0000-0002-2901-9595</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0023-6837
ispartof Laboratory investigation, 2021-10, Vol.101 (10), p.1331-1340
issn 0023-6837
1530-0307
language eng
recordid cdi_proquest_journals_2572354611
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects 13
13/51
14
14/19
14/35
631/1647/767/1658
64
692/617/375/1917/1285
82
96
Agglomeration
Aggregates
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - metabolism
Amyotrophic Lateral Sclerosis - pathology
Biocompatibility
Deoxyribonucleic acid
DNA
DNA-binding protein
DNA-Binding Proteins - chemistry
DNA-Binding Proteins - genetics
DNA-Binding Proteins - metabolism
FUS protein
Genetics
HEK293 Cells
HeLa Cells
Humans
In vivo methods and tests
Information processing
Laboratory Medicine
Liquid phases
Mammalian cells
Medicine
Medicine & Public Health
Mimicry
Mutation
Nuclear transport
Oligomerization
Optics
Pathology
Phase separation
Phase transitions
Proteins
RNA transport
Sarcoma
Toxicity
title Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T07%3A44%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Establishment%20of%20chemically%20oligomerizable%20TAR%20DNA-binding%20protein-43%20which%20mimics%20amyotrophic%20lateral%20sclerosis%20pathology%20in%20mammalian%20cells&rft.jtitle=Laboratory%20investigation&rft.au=Yamanaka,%20Yoshiaki&rft.date=2021-10-01&rft.volume=101&rft.issue=10&rft.spage=1331&rft.epage=1340&rft.pages=1331-1340&rft.issn=0023-6837&rft.eissn=1530-0307&rft_id=info:doi/10.1038/s41374-021-00623-4&rft_dat=%3Cproquest_cross%3E2572354611%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2572354611&rft_id=info:pmid/34131277&rft_els_id=S0023683722003968&rfr_iscdi=true